2014
DOI: 10.3109/10837450.2014.991874
|View full text |Cite
|
Sign up to set email alerts
|

Long-term controlled release of PLGA microparticles containing antidepressant mirtazapine

Abstract: The aim of the study was to prepare PLGA microparticles for prolonged release of mirtazapine by o/w solvent evaporation method and to evaluate effects of PVA concentration and organic solvent choice on microparticles characteristics (encapsulation efficiency, drug loading, burst effect, microparticle morphology). Also in vitro drug release tests were performed and the results were correlated with kinetic model equations to approximate drug release mechanism. It was found that dichloromethane provided micropart… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
6
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(6 citation statements)
references
References 36 publications
0
6
0
Order By: Relevance
“…In this context, n values between 0.45 and 0.89 are indicative of non-Fickian release which refers to a combination of both diffusion and erosion drug release mechanisms. 49 The observed n values for the release of ISMN from PLGA-MPs and PLGA-NPs of 0.74 and 0.66 respectively (R 2 4 0.95) is confirmation of non-Fickian behaviour. Such release characteristics could be attributed to the increase in strong entanglement bonds between the polymer matrixes which resisted the erosion by the dissolution medium in the initial hours of ISMN release.…”
Section: Resultsmentioning
confidence: 71%
“…In this context, n values between 0.45 and 0.89 are indicative of non-Fickian release which refers to a combination of both diffusion and erosion drug release mechanisms. 49 The observed n values for the release of ISMN from PLGA-MPs and PLGA-NPs of 0.74 and 0.66 respectively (R 2 4 0.95) is confirmation of non-Fickian behaviour. Such release characteristics could be attributed to the increase in strong entanglement bonds between the polymer matrixes which resisted the erosion by the dissolution medium in the initial hours of ISMN release.…”
Section: Resultsmentioning
confidence: 71%
“…Powder X-ray diffraction is used to determine whether a compound is in a crystalline or an amorphous state. When a crystalline drug is encapsulated in a microparticle formulation it loses its crystalline properties and exists in a molecularly dispersed (amorphous) form ( 36 ). The diffraction patterns of the SARM-loaded PLGA microparticles (F1 and F2) (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…The purpose of controlling the UV exposure with masks during crosslinking is to create unique heparin release profiles. The loading efficiency in heparin-loaded gelMA is extremely high when compared to other methods of drug encapsulation. ,, There is no clear change in loading efficiency caused by the masks or gelMA concentration, but both of these factors lead to differences in heparin release. The more gradual release in 7% 30 min No Mask corresponds to higher elastic modulus measured for this group, while the lower elastic moduli measured for 7% 30 min Mask 1 and 7% 30 min Mask 2 presented faster heparin release.…”
Section: Discussionmentioning
confidence: 99%